Global Next Generation Sequencing Market: Overview
An analysis of the market developments between 2016 and 2019 revealed that product launches & enhancements, partnerships, agreements, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the Next Generation Sequencing market. Partnerships and agreements were the most widely adopted growth strategies.
Get Access to Report Sample @ https://www.businessindustryreports.com/sample-request/270773
Global Next Generation Sequencing Market: Segmentation
On the basis of Product Type, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Targeted Sequencing & Resequencing, Whole Genome Sequencing, Whole Exome Sequencing. Based on End Users/Applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including Whole-genome Sequencing, Exome Sequencing, Targeted Resequencing, De Novo Sequencing, RNA Sequencing/ChIP Sequencing/Methyl Sequencing.
On the basis of technology, the NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. In 2018, the SBS segment accounted for the largest share of the NGS market. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of NGS platforms that use the SBS technology (including the HiSeq MiSeq series and NextSeq).
Global Next Generation Sequencing Market: Regional Analysis
Asia Pacific was a prominent market for Next Generation Sequencings in 2016. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India. These countries have been witnessing rapid increase in its population along with expansion of their overall economies, which has led to increase in disposable income. Increased spending on home interiors is fuelling the Next Generation Sequencing market in Asia Pacific.
There are several manufacturers of Next Generation Sequencings in Europe and North America. In North America, the demand for Next Generation Sequencings is primarily driven by the residential sector. Improved standards of living and rising usage of Next Generation Sequencings for flooring purpose are anticipated to drive the market in North America.
Global Next Generation Sequencing Market: Competitive Players
Some of the major players that operate in the Global Next Generation Sequencing Market are DNAnexus, DNASTAR, Eagle Genomics, Edge Biosystems, GENEWIZ, Roche, Agilent Technologies, Biomatters, CLC Bio, GATC biotech, Macrogen, BGI (Beijing Genomics Institute), Illumina, Life Technology, EMC, Dnastar.
Buy Next Generation Sequencing Market analysis & forecast 2020-2024 Report along with complete TOC@ https://www.businessindustryreports.com/buy-now/270773/single
Global Next Generation Sequencing Market: Regional Segment Analysis
North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
What Report Provides
Full in-depth analysis of the parent market
Important changes in market dynamics
Segmentation details of the market
Former, on-going, and projected market analysis in terms of volume and value
Assessment of niche industry developments
Market share analysis
Key strategies of major players
Emerging segments and regional markets
Testimonials to companies in order to fortify their foothold in the market.
Get Best Discount On This Report @ https://www.businessindustryreports.com/check-discount/270773
Latest Industry Updates:
Roche:-today announced that the US Food and Drug Administration (FDA) has approved Phesgo, a fixed-dose combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase, administered by subcutaneous (SC; under the skin) injection in combination with intravenous (IV) chemotherapy, for the treatment of early and metastatic HER2-positive breast cancer. This is the first time that Roche has combined two monoclonal antibodies that can be administered by a single SC injection.
“The FDA approval of Phesgo reflects our commitment to improving outcomes for the many people living with HER2-positive breast cancer,” said Levi Garraway, M.D., Ph.D., Chief Medical Officer and Head of Global Product Development. “Phesgo offers a treatment administration that supports the needs and preferences of individual patients, and helps to meet the increasing demand across the healthcare system for faster and more flexible treatment options.”
Phesgo is available in one single-dose vial. Administration can take approximately eight minutes for the initial loading dose and approximately five minutes for each subsequent maintenance dose. [1] This is compared to approximately 150 minutes for a sequential infusion of a loading dose of Perjeta and Herceptin using the standard IV formulations, and between 60-150 minutes for subsequent maintenance infusions of the two medicines. Phesgo can be administered by a healthcare professional in a treatment centre or at a patient’s home.
Table of Contents:
Global Next Generation Sequencing Market Report 2020
1 Next Generation Sequencing Definition
2 Global Next Generation Sequencing Market Major Player Share and Market Overview
3 Major Player Next Generation Sequencing Business Introduction
4 Global Next Generation Sequencing Market Segmentation (Region Level)
5 Global Next Generation Sequencing Market Segmentation (Product Type Level)
6 Global Next Generation Sequencing Market Segmentation (Industry Level)
7 Global Next Generation Sequencing Market Segmentation (Channel Level)
8 Next Generation Sequencing Market Forecast 2020-2024
………………. Request free sample to get a complete Table of Content
About us
BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.
Media Contact
Business Industry Reports
Pune – India
sales@businessindustryreports.com
+19376349940
This release was published on openPR.
